1 Department of Radiology, Division of Breast Imaging, Massachusetts General Hospital, Avon Comprehensive Breast Evaluation Center, Boston, MA.
2 Present address: H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Dr, Tampa, FL 33612.
AJR Am J Roentgenol. 2018 Nov;211(5):1171-1178. doi: 10.2214/AJR.17.18866. Epub 2018 Sep 12.
The purpose of this study is to evaluate the utility of MRI as a problem-solving tool for equivocal findings on diagnostic digital mammography (DM) and digital breast tomosynthesis (DBT).
Breast MRI examinations performed from March 2011 to November 2014 were retrospectively reviewed to identify those examinations that were performed to further assess equivocal findings on combined DM and DBT (DM/DBT) examinations. All patients underwent diagnostic ultrasound in conjunction with their DM/DBT examination. Imaging reports were retrospectively reviewed for BI-RADS findings and assessments of diagnostic DM/DBT and diagnostic MRI examinations. A review of the electronic medical records provided information on demographic data, cancer diagnoses, and pathologic findings. Differences in the positive predictive values and negative predictive values of DM/DBT and MRI were compared using a generalized estimating equation for correlated binary data.
Of 5330 MRI examinations performed during the study, 67 (1%) were performed for evaluation of an equivocal finding, including 27 asymmetries (40%), 16 focal asymmetries (24%), five masses (7%), and 19 architectural distortion (28%). MRI correlates were identified in 22 of 67 examinations (33%). Biopsies yielded a cancer diagnosis for five of 67 patients (7%). For MRI, the positive predictive value and negative predictive value were 19% and 98%, respectively, whereas for DM/DBT they were 6% and 90%, respectively (p = 0.009 and p = 0.059, respectively). The frequency of recommendations for breast MRI to evaluate equivocal findings decreased exponentially in the 3 years after DBT implementation.
As clinical implementation of DBT becomes increasingly widespread, breast radiologists need an algorithm for addressing the small number of inconclusive findings that remain equivocal despite thorough DM/DBT and ultrasound examinations. Breast MRI is a useful adjunctive tool for these selected cases.
本研究旨在评估 MRI 作为解决诊断性数字乳腺摄影术(DM)和数字乳腺断层合成术(DBT)中可疑发现问题的工具的效用。
回顾性分析 2011 年 3 月至 2014 年 11 月期间进行的乳腺 MRI 检查,以确定那些用于进一步评估 DM/DBT 联合检查中可疑发现的检查。所有患者均在接受 DM/DBT 检查的同时进行了诊断性超声检查。回顾性分析影像学报告,以获取 BI-RADS 发现以及 DM/DBT 和诊断性 MRI 检查的评估结果。查阅电子病历,获取人口统计学数据、癌症诊断和病理发现信息。采用相关二元数据广义估计方程比较 DM/DBT 和 MRI 的阳性预测值和阴性预测值的差异。
在研究期间进行的 5330 次 MRI 检查中,有 67 次(1%)是为评估可疑发现而进行的,包括 27 次不对称(40%)、16 次局灶性不对称(24%)、5 次肿块(7%)和 19 次结构扭曲(28%)。在 67 次检查中的 22 次检查中发现了 MRI 相关性。对 67 例患者中的 5 例进行了活检,发现了癌症诊断。对于 MRI,阳性预测值和阴性预测值分别为 19%和 98%,而对于 DM/DBT,它们分别为 6%和 90%(p = 0.009 和 p = 0.059)。在 DBT 实施后的 3 年内,评估可疑发现建议进行乳腺 MRI 的频率呈指数下降。
随着 DBT 的临床应用越来越广泛,乳腺放射科医生需要一种算法来处理尽管经过了 DM/DBT 和超声检查,但仍存在不确定的少量不确定发现。在这些选定的病例中,乳腺 MRI 是一种有用的辅助工具。